David Neu named president of AmerisourceBergen Drug Corporation
This article was originally published in Scrip
Executive Summary
AmerisourceBergen, a pharmaceutical services companies serving the US, Canada and selected global markets, has promoted David Neu to president of AmerisourceBergen Drug Corporation (ABCD), the company's largest operating unit. Mr Neu, a 29-year veteran of the company, was most recently senior vice-president of operations for ABDC. He fills the role previously held by Steven Collis, currently executive vice-president and chief operating officer, who was recently named successor to the company's CEO, David Yost, upon his retirement on 1 July.